LGALS3 and pancreatic neoplasm: With respect to diagnostic value in pancreatic cancer, our meta-analysis suggested that the pooled DOR of galectin-3 was 5.93, but the 95% CI was 0.96–36.72, indicating an unsatisfactory diagnostic accuracy and substantial heterogeneity.